Major, Inc.
MAJOR INC conducts life‑sciences and biotechnology research focused on developing noninvasive, preventative therapeutics. The organization works with academic partners to advance preclinical programs aimed at reducing viral load and infection, and publishes and shares research outputs and collaboration opportunities.
Industries
N/A
Services
Collaborative research partnerships
Partnering with academic groups and external collaborators to advance research programs and share findings.
Preclinical research and candidate evaluation
Preclinical testing and evaluation of therapeutic candidates, including efficacy assessments intended for prophylactic use.
Collaborative research partnerships
Partnering with academic groups and external collaborators to advance research programs and share findings.
Preclinical research and candidate evaluation
Preclinical testing and evaluation of therapeutic candidates, including efficacy assessments intended for prophylactic use.
Expertise Areas
- Antiviral therapeutics research
- Preclinical development and in vivo efficacy testing
- Peptidomimetic drug discovery
- Translational research
Key Technologies
- Peptidomimetic (peptoid) chemistry
- Preclinical in vivo models
- Antiviral prophylactic therapeutics
- Assay-based candidate screening